Synergen Bio Pvt. Ltd. is a new age Contract Research Organization (CRO) with a vision to establish itself as a premium player known for its Quality, Knowledge, and Expertise. They offer a broad range of comprehensive, integrated drug development, product development, Phase I-IV clinical development, BA/BE Studies, and data solution services to organizations in the pharmaceutical, biotechnology, medical device, academic and government sectors globally. With over 30 clinical research projects in various therapeutic indications, including Gastrology, Hepatology, Oncology, Rheumatology, Hematology, and Cardiovascular, Synergen Bio has a wealth of experience. Their core values are centered around commitment, flexibility, value creation, and global reach. The company is committed to delivering high-quality projects meeting regulatory requirements in full compliance with GCP, GLP, and ensuring adherence to approved protocols, regulatory, ethical, and scientific norms. Founded in 2018, Synergen Bio is dedicated to offering total service satisfaction to its customers and continuously improving its processes, systems, and services. With a website at www.synergenbio.com, they aim to provide end-to-end guidance or flexible multiple services. However, specific details about the company's headquarters, last investment, and investors are not available. Overall, Synergen Bio possesses a strong foundation within the Biotechnology and Pharmaceutical industries, positioning it as an intriguing prospect for potential investors in the healthcare sector.
There is no investment information
No recent news or press coverage available for Synergen Bio Pvt. Ltd..